Overview

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Status:
Completed
Trial end date:
2017-08-15
Target enrollment:
Participant gender:
Summary
This trial is to designed to assess the efficacy and safety of Cryotherapy combine with Icotinib for Advanced NSCLC Patients harboring EGFR mutation.
Phase:
Phase 4
Details
Lead Sponsor:
Fuda Cancer Hospital, Guangzhou